The prevention of radiosurgery-induced nausea and vomiting by ondansetron: Evidence of a direct effect on the central nervous system chemoreceptor trigger zone
- 1 September 1994
- journal article
- clinical trial
- Published by Elsevier in Surgical Neurology
- Vol. 42 (3) , 249-252
- https://doi.org/10.1016/0090-3019(94)90272-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?BMJ, 1991
- Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.Journal of Clinical Oncology, 1991
- Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.Journal of Clinical Oncology, 1991
- Antiemetic Efficacy and pharmacokientic Analysis of the Serotonin Antagonist Ondansetron (GR 38032F) During Multiple-Day Chemotherphy With Cisplatin Prior to Autologous Bone Marrow TransplantationJNCI Journal of the National Cancer Institute, 1990
- Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effectsRadiotherapy and Oncology, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- The acute onset of nausea and vomiting following stereotactic radiosurgery: Correlation with total dose to area postremaSurgical Neurology, 1989